{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:47:16Z","timestamp":1791895636372,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Department of Science and Technology of the Jilin Province","award":["20220204004YY"],"award-info":[{"award-number":["20220204004YY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the present study, we aimed to develop a novel isotretinoin delivery model for treating skin diseases, revealing its potential advantages in drug delivery and targeted therapy.<\/jats:p>\n                <jats:p>Using a self-assembly strategy, we grafted a dendrimer, based on a well-defined branched structure for nanomedical devices, with a well-defined nanoarchitecture, yielding spherical, highly homogeneous molecules with multiple surface functionalities. Accordingly, a self-assembled dendrimer-conjugated system was developed to achieve the transdermal delivery of isotretinoin (13cRA-D).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Herein, 13cRA-D showed remarkable controlled release, characterized by slow release in normal tissues but accelerated release in tissues with low pH, such as sites of inflammation. These release characteristics could abrogate the nonteratogenic side effects of isotretinoin and allow efficient skin permeation. Moreover, 13cRA-D exhibited high therapeutic efficacy in acne models. Based on in vitro and in vivo experimental results, 13cRA-D afforded better skin penetration than isotretinoin and allowed lesion targeting. Additionally, 13cRA-D induced minimal skin irritation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings suggest that 13cRA-D is a safe and effective isotretinoin formulation for treating patients with skin disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-023-02052-5","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:02:59Z","timestamp":1692640979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Dendrimer-conjugated isotretinoin for controlled transdermal drug delivery"],"prefix":"10.1186","volume":"21","author":[{"given":"Tianqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingji","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myongsoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"issue":"2","key":"2052_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000090646","volume":"212","author":"CC Zouboulis","year":"2006","unstructured":"Zouboulis CC. The truth behind this undeniable efficacy\u2014recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology. 2006;212(2):99\u2013100.","journal-title":"Dermatology"},{"issue":"Suppl 1","key":"2052_CR2","first-page":"S47","volume":"8","author":"R Ganceviciene","year":"2010","unstructured":"Ganceviciene R, Zouboulis CC. Isotretinoin for acne vulgaris: state-of-the-art treatment for acne vulgaris. J Dtsch Dermatol Ges. 2010;8(Suppl 1):S47-59.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10","key":"2052_CR3","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1111\/jdv.16430","volume":"34","author":"C Dessinioti","year":"2020","unstructured":"Dessinioti C, Zouboulis CC, Bettoli V, Rigopoulos D. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol. 2020;34(10):2229\u201340.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2052_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1468-3083.2008.02947.x","volume":"23","author":"RM Rabello-Fonseca","year":"2009","unstructured":"Rabello-Fonseca RM, Azulay DR, Luiz RR, Mandarim-de-Lacerda CA, Cuzzi T, Manela-Azulay M. Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication. J Eur Acad Dermatol Venereol. 2009;23(2):115\u201323.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2052_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jamadermatol.2015.3091","volume":"152","author":"YH Lee","year":"2016","unstructured":"Lee YH, Scharnitz TP, Muscat J, Chen A, Gupta-Elera G, Kirby JS. Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(1):35\u201344.","journal-title":"JAMA Dermatol"},{"issue":"12","key":"2052_CR6","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","volume":"149","author":"RC Blasiak","year":"2013","unstructured":"Blasiak RC, Stamey CR, Burkhart CN, Lugo-Somolinos A, Morrell DS. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. 2013;149(12):1392\u20138.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"2052_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/j.1552-4604.1997.tb04303.x","volume":"37","author":"C Chen","year":"1997","unstructured":"Chen C, Jensen BK, Mistry G, Wyss R, Zultak M, Patel IH, et al. Negligible systemic absorption of topical isotretinoin cream: implications for teratogenicity. J Clin Pharmacol. 1997;37(4):279\u201384.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"2052_CR8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261\u20138.","journal-title":"Nat Biotechnol"},{"key":"2052_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addr.2017.08.009","volume":"127","author":"H Lee","year":"2018","unstructured":"Lee H, Song C, Baik S, Kim D, Hyeon T, Kim DH. Device-assisted transdermal drug delivery. Adv Drug Deliv Rev. 2018;127:35\u201345.","journal-title":"Adv Drug Deliv Rev"},{"key":"2052_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.addr.2013.11.014","volume":"73","author":"MB Delgado-Charro","year":"2014","unstructured":"Delgado-Charro MB, Guy RH. Effective use of transdermal drug delivery in children. Adv Drug Deliv Rev. 2014;73:63\u201382.","journal-title":"Adv Drug Deliv Rev"},{"key":"2052_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jconrel.2017.11.049","volume":"270","author":"VK Rai","year":"2018","unstructured":"Rai VK, Mishra N, Yadav KS, Yadav NP. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J Control Release. 2018;270:203\u201325.","journal-title":"J Control Release"},{"key":"2052_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coph.2017.07.007","volume":"36","author":"K Moffatt","year":"2017","unstructured":"Moffatt K, Wang Y, Raj Singh TR, Donnelly RF. Microneedles for enhanced transdermal and intraocular drug delivery. Curr Opin Pharmacol. 2017;36:14\u201321.","journal-title":"Curr Opin Pharmacol"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2016.09.008","volume":"242","author":"M Ashtikar","year":"2016","unstructured":"Ashtikar M, Nagarsekar K, Fahr A. Transdermal delivery from liposomal formulations\u2014evolution of the technology over the last three decades. J Control Release. 2016;242:126\u201340.","journal-title":"J Control Release"},{"issue":"10","key":"2052_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1021\/js980025k","volume":"87","author":"TM Morgan","year":"1998","unstructured":"Morgan TM, Reed BL, Finnin BC. Enhanced skin permeation of sex hormones with novel topical spray vehicles. J Pharm Sci. 1998;87(10):1213\u20138.","journal-title":"J Pharm Sci"},{"key":"2052_CR15","first-page":"383","volume-title":"Transdermal drug delivery (2nd Edition, revised and expanded)","author":"AL Stinchcomb","year":"2003","unstructured":"Stinchcomb AL, Guy RH, Hadgraft J. Transdermal drug delivery (2nd Edition, revised and expanded). New York: Marcel Dekker; 2003. p. 383."},{"issue":"2","key":"2052_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd1304","volume":"3","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115\u201324.","journal-title":"Nat Rev Drug Discov"},{"key":"2052_CR17","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1201\/9780849359033","volume-title":"Percutaneous absorption","author":"RL Bronaugh","year":"2005","unstructured":"Bronaugh RL, Maibach HI. Percutaneous absorption. Boca Raton: Taylor and Francis;CRC Press; 2005. p. 2005."},{"key":"2052_CR18","volume-title":"Transdermal and topical drug delivery","author":"HE Benson","year":"2012","unstructured":"Benson HE, Watkinson A. Transdermal and topical drug delivery. In: Heather A, Benson E, Watkinson AC, editors. Transdermal and topical drug delivery. Hoboken: Wiley; 2012."},{"key":"2052_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2017.07.003","volume":"262","author":"SA Castleberry","year":"2017","unstructured":"Castleberry SA, Quadir MA, Sharkh MA, Shopsowitz KE, Hammond PT. Polymer conjugated retinoids for controlled transdermal delivery. J Control Release. 2017;262:1\u20139.","journal-title":"J Control Release"},{"issue":"2","key":"2052_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/anie.199001381","volume":"29","author":"DA Tomalia","year":"1990","unstructured":"Tomalia DA, Naylor AM, Goddard WA III. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem, Int Ed Engl. 1990;29(2):138\u201375.","journal-title":"Angew Chem, Int Ed Engl"},{"issue":"6","key":"2052_CR21","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1021\/ja00188a079","volume":"111","author":"AM Naylor III","year":"2002","unstructured":"Naylor AM III, WA G, Kiefer GE, Tomalia DA. Starburst dendrimers. 5. molecular shape control. J Am Chem Soc. 2002;111(6):2339.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"2052_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6700(97)00025-7","volume":"23","author":"OA Matthews","year":"1998","unstructured":"Matthews OA, Shipway AN, Stoddart JF. Dendrimers-Branching out from curiosities into new technologies. Prog Polym Sci. 1998;23(1):1\u201356.","journal-title":"Prog Polym Sci"},{"key":"2052_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2018.06.005","volume":"257","author":"LJ Fox","year":"2018","unstructured":"Fox LJ, Richardson RM, Briscoe WH. PAMAM dendrimer\u2014cell membrane interactions. Adv Coll Interface Sci. 2018;257:1\u201318.","journal-title":"Adv Coll Interface Sci"},{"issue":"79","key":"2052_CR24","doi-asserted-by":"publisher","first-page":"10958","DOI":"10.1039\/C7CC05869A","volume":"53","author":"X Chen","year":"2017","unstructured":"Chen X, Wang Y, Wang H, Kim Y, Lee M. \u03b1-Helical peptide vesicles with chiral membranes as enantioselective nanoreactors. Chem Commun. 2017;53(79):10958\u201361.","journal-title":"Chem Commun"},{"issue":"6","key":"2052_CR25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1046\/j.1523-1747.1999.00771.x","volume":"113","author":"CC Zouboulis","year":"1999","unstructured":"Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol. 1999;113(6):1011\u201320.","journal-title":"J Invest Dermatol"},{"issue":"14","key":"2052_CR26","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1039\/D1QO00440A","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Feng X, Lee M. Self-division of 2-D sheets in aromatic macrocycle assembly. Org Chem Front. 2021;8(14):3681\u20135.","journal-title":"Org Chem Front"},{"issue":"7","key":"2052_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41563-018-0107-4","volume":"17","author":"B Sun","year":"2018","unstructured":"Sun B, Kim Y, Wang Y, Wang H, Kim J, Liu X, et al. Homochiral porous nanosheets for enantiomer sieving. Nat Mater. 2018;17(7):599\u2013604.","journal-title":"Nat Mater"},{"issue":"1","key":"2052_CR28","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41467-019-09099-9","volume":"10","author":"B Shen","year":"2019","unstructured":"Shen B, Zhu Y, Kim Y, Zhou X, Sun H, Lu Z, et al. Autonomous helical propagation of active toroids with mechanical action. Nat Commun. 2019;10(1):1080.","journal-title":"Nat Commun"},{"key":"2052_CR29","doi-asserted-by":"publisher","first-page":"11355","DOI":"10.1002\/anie.202003807","volume":"59","author":"X Feng","year":"2020","unstructured":"Feng X, Shen B, Sun B, Kim J, Liu X, Lee M. Single-layered chiral nanosheets with dual chiral void spaces for highly efficient enantiomer absorption. Angew Chem Int Ed. 2020;59:11355.","journal-title":"Angew Chem Int Ed"},{"key":"2052_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0041-008X(81)90310-0","volume":"59","author":"CRD Bruce","year":"1981","unstructured":"Bruce CRD. Comparative dermatotoxicology: i. direct comparison of rabbit and human primary skin irritation responses to isopropylmyristate. Toxicol Appl Pharmacol. 1981;59:555.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"2052_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2133.1979.tb08075.x","volume":"100","author":"M Ka","year":"1979","unstructured":"Ka M, T K. An improved rabbit ear model for assessing comedogenic substances. Br J Dermatol. 1979;100(6):699.","journal-title":"Br J Dermatol"},{"issue":"9","key":"2052_CR32","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/jcb.25856","volume":"118","author":"XG Liang","year":"2017","unstructured":"Liang XG, Meng WT, Hu LJ, Li L, Xing H, Xie G, et al. MicroRNA-184 modulates human central nervous system lymphoma cells growth and invasion by targeting iASPP. J Cell Biochem. 2017;118(9):2645\u201353.","journal-title":"J Cell Biochem"},{"issue":"2","key":"2052_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2133.1992.tb07805.x","volume":"126","author":"BS Baker","year":"1992","unstructured":"Baker BS, Brent L, Valdimarsson H, Powles AV, AL-Imara L, Walker M, et al. Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? Br J Dermatol. 1992;126(2):105\u201310.","journal-title":"Br J Dermatol"},{"issue":"4","key":"2052_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/molecules23040938","volume":"23","author":"AS Chauhan","year":"2018","unstructured":"Chauhan AS. Dendrimers for drug delivery. Molecules. 2018;23(4):938.","journal-title":"Molecules"},{"issue":"7203","key":"2052_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335.","journal-title":"Nature"},{"issue":"1","key":"2052_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12951-020-00664-9","volume":"18","author":"S Wang","year":"2020","unstructured":"Wang S, Jiang R, Meng T, Zhang F, Li J, Jin Y, et al. Stem cell membrane-coated isotretinoin for acne treatment. J Nanobiotechnol. 2020;18(1):106.","journal-title":"J Nanobiotechnol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02052-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-02052-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02052-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T12:23:55Z","timestamp":1700396635000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-02052-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-02052-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed according to the guidelines for the Care and Use of Experimental Animals of Jilin University and were approved by the Animal Experiment Ethics Committee of Jilin University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}